RA CAPITAL MANAGEMENT, L.P.
CIK 1346824 · View on SEC EDGAR ↗
- Portfolio value
- $11.5B
- Positions
- 84
- As of
- June 30, 2026
#438 of 9,443 by 13F value · top 4.6%
Portfolio value QoQ: +21.8% 13F does not disclose cash
- Top 10 holdings weight
- 60.59%
- Top 25 holdings weight
- 82.33%
- Positions above 1%
- 25
- Effective number of positions
- 12.7
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 33.11% Est. buys $4,664,404,899 · sells $3,459,175,401
Median holding: 3.0 quarters Tracked Q4 2024–Q2 2026 · 48.6% still held
- New positions
- 17
- Increased
- 10
- Decreased
- 10
- Closed
- 17
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
- Related The person behind this filer, where we can match one.
Performance vs S&P 500
Annualized: +30.8% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 97.0% · Options excluded: 0.0%
Sector breakdown
Healthcare
63.7%
N/A
0.1%
Other/Unmapped
36.2%
Full portfolio 84 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| Unknown issuer (CUSIP: K08588103) | $2,742,280,613 | 23.90% | 10,281,496 | Up ×1 | |||
| Unknown issuer (CUSIP: 698955101) | $791,906,364 | 6.90% | 28,933,371 | Up ×1 | |||
| RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | $740,218,912 | 6.45% | 6,666,837 | $160,404,098 | |||
| PCVX Vaxcyte, Inc. - Common Stock | $667,018,440 | 5.81% | 11,474,599 | $229,492 | |||
| SION Sionna Therapeutics, Inc. - Common Stock | $435,722,930 | 3.80% | 9,905,045 | $38,629,676 | |||
| TYRA Tyra Biosciences, Inc. - Common Stock | $389,624,083 | 3.40% | 12,198,625 | $-77,583,255 | |||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $340,996,620 | 2.97% | 8,392,730 | $12,500,854 | Down ×1 | ||
| NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | $323,655,973 | 2.82% | 9,550,191 | $17,954,359 | |||
| Unknown issuer (CUSIP: 423494103) | $286,810,870 | 2.50% | 7,808,627 | Up ×1 | |||
| SEPN Septerna, Inc. - Common Stock | $234,291,284 | 2.04% | 6,995,858 | $66,180,816 | |||
| BCAX Bicara Therapeutics Inc. - Common Stock | $215,430,432 | 1.88% | 7,255,993 | $71,108,731 | |||
| MLYS Mineralys Therapeutics, Inc. - Common Stock | $207,550,395 | 1.81% | 7,692,750 | $-846,203 | |||
| GHRS GH Research PLC - Ordinary Shares | $205,277,533 | 1.79% | 7,636,813 | $97,343,173 | Down ×1 | ||
| IRON Disc Medicine, Inc. - Common Stock | $179,209,164 | 1.56% | 2,450,221 | $22,542,033 | |||
| SGP SpyGlass Pharma, Inc. - Common Stock | $178,550,064 | 1.56% | 8,021,117 | $-29,277,077 | |||
| ARTV Artiva Biotherapeutics, Inc. - Common Stock | $174,169,727 | 1.52% | 17,955,642 | $110,714,462 | Up ×1 | ||
| JANX Janux Therapeutics, Inc. - Common Stock | $171,873,684 | 1.50% | 11,189,693 | $16,336,951 | |||
| TSHA Taysha Gene Therapies, Inc. - Common Stock | $160,413,963 | 1.40% | 23,555,648 | $55,120,216 | |||
| BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | $158,271,860 | 1.38% | 15,827,186 | $7,597,049 | |||
| WVE Wave Life Sciences Ltd. - Ordinary Shares | $156,727,684 | 1.37% | 26,975,505 | $-38,844,727 | |||
| NUVL Nuvalent, Inc. - Class A Common Stock | $153,937,316 | 1.34% | 1,246,456 | $-105,685,839 | Down ×1 | ||
| ABVX Abivax SA - American Depositary Shares | $150,924,546 | 1.32% | 1,132,557 | Up ×1 | |||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $147,950,996 | 1.29% | 1,554,597 | Up ×1 | |||
| SLDB Solid Biosciences Inc. - Common Stock | $120,240,899 | 1.05% | 12,036,126 | $52,993,057 | Up ×2 | ||
| CLYM Climb Bio, Inc. - Common Stock | $115,026,714 | 1.00% | 8,821,067 | $54,602,405 | |||
| ZLAB Zai Lab Limited - American Depositary Shares | $109,127,127 | 0.95% | 5,743,533 | $1,773,529 | Up ×1 | ||
| SPRY ARS Pharmaceuticals, Inc. - Common Stock | $86,996,426 | 0.76% | 10,860,977 | $-217,219 | |||
| XNCR Xencor, Inc. - Common Stock | $84,915,811 | 0.74% | 5,274,274 | $25,855,133 | Up ×1 | ||
| JBIO Jade Biosciences, Inc. - Common Stock | $81,571,464 | 0.71% | 3,671,083 | $29,992,748 | |||
| NTLA Intellia Therapeutics, Inc. - Common Stock | $76,595,588 | 0.67% | 4,526,926 | Up ×1 | |||
| LBRX LB Pharmaceuticals Inc - Common Stock | $71,680,243 | 0.62% | 2,208,604 | $17,216,068 | |||
| DFTX Definium Therapeutics, Inc. - Common Shares | $70,560,000 | 0.61% | 1,500,000 | Up ×1 | |||
| ACRS Aclaris Therapeutics, Inc. - Common Stock | $67,304,808 | 0.59% | 12,723,026 | $41,789,538 | Up ×1 | ||
| FDMT 4D Molecular Therapeutics, Inc. - Common Stock | $67,162,061 | 0.59% | 5,049,779 | $20,148,619 | |||
| SANA Sana Biotechnology, Inc. - Common Stock | $65,437,500 | 0.57% | 18,750,000 | Up ×1 | |||
| GLTO Galecto, Inc. - Common Stock | $62,416,249 | 0.54% | 2,399,702 | $274,120 | Up ×1 | ||
| MNPR Monopar Therapeutics Inc. - Common Stock | $61,776,696 | 0.54% | 667,207 | $25,220,424 | |||
| ABOS Acumen Pharmaceuticals, Inc. - Common Stock | $56,050,426 | 0.49% | 20,992,669 | $6,507,727 | |||
| GERN Geron Corporation - Common Stock | $54,796,481 | 0.48% | 42,809,751 | $-40,222,854 | Down ×1 | ||
| RZLT Rezolute, Inc. - Common Stock (NV) | $49,114,203 | 0.43% | 9,445,039 | $21,115,203 | Up ×1 | ||
| EVMN Evommune, Inc. Common Stock | $46,443,739 | 0.40% | 3,494,638 | $-33,897,989 | |||
| VOR Vor Biopharma Inc. - Common Stock | $44,222,569 | 0.39% | 2,402,095 | $-52,202,595 | Down ×1 | ||
| IPSC Century Therapeutics, Inc. - Common Stock | $43,498,354 | 0.38% | 17,754,430 | $3,373,342 | |||
| AKTS Aktis Oncology, Inc. - Common stock | $42,363,273 | 0.37% | 1,314,405 | $15,473,100 | Down ×1 | ||
| BIOA BioAge Labs, Inc. - Common Stock | $40,972,092 | 0.36% | 1,671,648 | $12,102,258 | Up ×1 | ||
| CCCC C4 Therapeutics, Inc. - Common Stock | $37,360,000 | 0.33% | 8,000,000 | $16,320,000 | |||
| MIRM Mirum Pharmaceuticals, Inc. - common stock | $37,293,117 | 0.32% | 318,554 | $7,865,098 | |||
| CAPR Capricor Therapeutics, Inc. - Common Stock | $36,308,884 | 0.32% | 1,507,844 | $-9,529,574 | |||
| PEPG PepGen Inc. - Common Stock | $36,116,181 | 0.31% | 20,064,545 | $601,936 | |||
| PRLD Prelude Therapeutics Incorporated - Common Stock | $34,516,451 | 0.30% | 6,475,882 | Up ×1 | |||
| NKTX Nkarta, Inc. - Common Stock | $30,578,515 | 0.27% | 10,805,129 | $7,779,693 | |||
| QTTB Q32 Bio Inc. - Common Stock | $29,715,502 | 0.26% | 2,332,457 | Up ×1 | |||
| AVR Anteris Technologies Global Corp. - Common Stock | $29,550,000 | 0.26% | 3,000,000 | $12,900,000 | |||
| EDIT Editas Medicine, Inc. - Common Stock | $28,800,360 | 0.25% | 8,889,000 | Up ×1 | |||
| OVID Ovid Therapeutics Inc. - Common Stock | $28,247,604 | 0.25% | 10,500,968 | $4,462,524 | Down ×1 | ||
| ASMB Assembly Biosciences, Inc. - Common Stock | $28,040,867 | 0.24% | 1,020,410 | $-275,511 | |||
| ALXO ALX Oncology Holdings Inc. - Common Stock | $26,934,527 | 0.23% | 13,011,849 | $845,770 | |||
| BNTC Benitec Biopharma Inc. - Common Stock | $24,753,000 | 0.22% | 1,850,000 | $5,050,500 | |||
| LENZ LENZ Therapeutics, Inc. - Common Stock | $23,735,715 | 0.21% | 4,178,823 | $-14,500,515 | |||
| LXEO Lexeo Therapeutics, Inc. - Common Stock | $23,275,000 | 0.20% | 5,000,000 | $-5,425,000 | |||
| ACRV Acrivon Therapeutics, Inc. - Common Stock | $21,768,325 | 0.19% | 12,229,396 | $10,175,019 | Up ×1 | ||
| ALT Altimmune, Inc. - Common Stock | $19,760,000 | 0.17% | 6,500,000 | Up ×1 | |||
| KPTI Karyopharm Therapeutics Inc. - Common Stock | $18,732,549 | 0.16% | 1,917,354 | $8,052,887 | |||
| DRUG Bright Minds Biosciences Inc. - common stock | $18,603,000 | 0.16% | 265,000 | $-734,050 | |||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $18,480,000 | 0.16% | 1,000,000 | $8,581,888 | Up ×1 | ||
| OKUR OnKure Therapeutics, Inc. - Class A Common Stock | $18,232,398 | 0.16% | 3,998,333 | $1,679,299 | |||
| SNSE Sensei Biotherapeutics, Inc. - Common Stock | $18,050,500 | 0.16% | 722,020 | Up ×1 | |||
| AURA Aura Biosciences, Inc. - Common Stock | $17,750,000 | 0.15% | 2,500,000 | Up ×1 | |||
| SABS SAB Biotherapeutics, Inc. - Common Stock | $17,165,850 | 0.15% | 4,401,500 | $308,105 | |||
| Unknown issuer (CUSIP: 81221K108) | $15,204,000 | 0.13% | 700,000 | Up ×1 | |||
| PALI Palisade Bio, Inc. - Common Stock | $14,889,402 | 0.13% | 7,124,116 | $2,422,199 | |||
| HLXC Helix Acquisition Corp. III - Class A Ordinary Shares | $13,300,000 | 0.12% | 1,250,000 | $600,000 | |||
| WAY Waystar Holding Corp. - Common Stock | $10,868,582 | 0.09% | 529,400 | $-1,895,252 | |||
| EQ Equillium, Inc. - Common Stock | $9,908,275 | 0.09% | 3,096,336 | $3,715,603 | |||
| MGNX MacroGenics, Inc. - Common Stock | $8,612,493 | 0.08% | 1,864,176 | $3,225,024 | |||
| PCSC Perceptive Capital Solutions Corp - Class A Ordinary Shares | $8,160,000 | 0.07% | 750,000 | $-67,500 | |||
| ACET Adicet Bio, Inc. - Common Stock | $8,057,871 | 0.07% | 932,624 | $4,202 | Down ×1 | ||
| NAMSW NewAmsterdam Pharma Company N.V. - Warrant | $7,123,326 | 0.06% | 333,333 | $443,333 | |||
| CRVS Corvus Pharmaceuticals, Inc. - Common Stock | $6,723,000 | 0.06% | 450,000 | $139,500 | |||
| RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | $6,463,400 | 0.06% | 8,500,000 | $217,600 | |||
| Unknown issuer (CUSIP: G50765109) | $5,680,000 | 0.05% | 500,000 | Up ×1 | |||
| Unknown issuer (CUSIP: G0375M101) | $3,810,000 | 0.03% | 375,000 | Up ×1 | |||
| HOWL Werewolf Therapeutics, Inc. - Common Stock | $859,349 | 0.01% | 2,387,744 | $-4,703,507 | Down ×1 | ||
| PTN Palatin Technologies, Inc. - Common Stock | $670,318 | 0.01% | 62,124 | $-549,082 | Down ×1 | ||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| Unknown issuer (CUSIP: K08588103) | $2,742,280,613 | 10,281,496 | 23.90% |
| Unknown issuer (CUSIP: 698955101) | $791,906,364 | 28,933,371 | 6.90% |
| Unknown issuer (CUSIP: 423494103) | $286,810,870 | 7,808,627 | 2.50% |
| ABVX | $150,924,546 | 1,132,557 | 1.32% |
| ORKA | $147,950,996 | 1,554,597 | 1.29% |
| NTLA | $76,595,588 | 4,526,926 | 0.67% |
| DFTX | $70,560,000 | 1,500,000 | 0.61% |
| SANA | $65,437,500 | 18,750,000 | 0.57% |
| PRLD | $34,516,451 | 6,475,882 | 0.30% |
| QTTB | $29,715,502 | 2,332,457 | 0.26% |
| EDIT | $28,800,360 | 8,889,000 | 0.25% |
| ALT | $19,760,000 | 6,500,000 | 0.17% |
| SNSE | $18,050,500 | 722,020 | 0.16% |
| AURA | $17,750,000 | 2,500,000 | 0.15% |
| Unknown issuer (CUSIP: 81221K108) | $15,204,000 | 700,000 | 0.13% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| RYTM | Price move only | +0 | +$160.4M |
| ARTV | Bought more | +8.1M | +$110.7M |
| NUVL | Trimmed | -1.3M | -$105.7M |
| GHRS | Trimmed | -40K | +$97.3M |
| TYRA | Price move only | +0 | -$77.6M |
| BCAX | Price move only | +0 | +$71.1M |
| SEPN | Price move only | +0 | +$66.2M |
| TSHA | Price move only | +0 | +$55.1M |
| CLYM | Price move only | +0 | +$54.6M |
| SLDB | Bought more | +2.7M | +$53.0M |
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| ASND | June 30, 2026 | 10,281,496 | $2,351,686,580 | -2.8% |
| CDTX | March 31, 2026 | 3,365,523 | $743,410,375 | No longer tracked |
| RNA | March 31, 2026 | 8,641,031 | $623,277,566 | 1.9% |
| ETNB | Dec. 31, 2025 | 19,889,683 | $292,378,340 | No longer tracked |
| LEGN | March 31, 2025 | 7,506,934 | $244,275,632 | -33.9% |
| DNTH | June 30, 2026 | 2,611,733 | $219,176,633 | 13.9% |
| PRAX | June 30, 2026 | 373,787 | $120,430,434 | 13.2% |
| XBI | March 31, 2025 | 1,228,240 | $110,615,294 | No longer tracked |
| DYN | Sept. 30, 2025 | 9,714,392 | $92,481,012 | 105.7% |
| SRPT | June 30, 2026 | 3,902,596 | $84,920,489 | 6.6% |
| AXSM | March 31, 2025 | 1,000,000 | $84,610,000 | 85.5% |
| ACLX | March 31, 2026 | 1,267,156 | $82,618,571 | No longer tracked |
| VRNA | March 31, 2025 | 1,766,830 | $82,051,585 | No longer tracked |
| SYRE | June 30, 2026 | 1,621,620 | $81,794,513 | 19.3% |
| BLTE | March 31, 2026 | 432,484 | $69,180,141 | 6.3% |
| VORXXXX | Sept. 30, 2025 | 39,646,039 | $64,226,583 | No longer tracked |
| PRAX | March 31, 2025 | 761,955 | $58,640,057 | 900.8% |
| APGE | June 30, 2025 | 1,569,491 | $58,636,184 | 210.2% |
| RXRX | March 31, 2025 | 7,725,096 | $52,221,649 | -36.7% |
| RXST | Sept. 30, 2025 | 3,702,967 | $48,138,571 | -31.4% |
| ZLAB | June 30, 2025 | 1,295,040 | $46,802,746 | -25.1% |
| FULC | June 30, 2026 | 6,053,960 | $46,433,873 | 5.7% |
| DAWN | June 30, 2025 | 5,755,577 | $45,641,726 | No longer tracked |
| SRRK | Dec. 31, 2025 | 1,166,788 | $43,451,185 | 25.8% |
| GPCR | Dec. 31, 2025 | 1,517,418 | $42,487,704 | -23.4% |
| IVVD | March 31, 2026 | 17,119,096 | $42,284,167 | -24.3% |
| TRML | Sept. 30, 2025 | 2,538,925 | $40,597,411 | No longer tracked |
| EVH | March 31, 2025 | 3,577,197 | $40,243,466 | -51.7% |
| OLMA | June 30, 2026 | 2,600,000 | $38,766,000 | -12.5% |
| URGN | June 30, 2025 | 3,206,271 | $35,461,357 | 258.4% |
| MTSR | Dec. 31, 2025 | 675,525 | $35,350,223 | No longer tracked |
| DSGN | June 30, 2026 | 2,972,973 | $31,632,433 | 7.9% |
| CMRX | March 31, 2025 | 8,800,000 | $30,624,000 | No longer tracked |
| TVTX | Dec. 31, 2025 | 1,150,000 | $27,485,000 | 69.7% |
| ATXS | June 30, 2025 | 5,105,213 | $27,261,837 | No longer tracked |
| KURA | June 30, 2025 | 4,004,610 | $26,430,426 | 111.0% |
| AVTE | June 30, 2025 | 9,192,092 | $23,072,151 | No longer tracked |
| TVTX | June 30, 2026 | 746,841 | $22,188,646 | 14.1% |
| GRAL | June 30, 2026 | 428,266 | $22,132,787 | 9.5% |
| IDYA | June 30, 2025 | 1,347,252 | $22,067,988 | 81.4% |
| ITOS | June 30, 2025 | 3,649,057 | $21,784,870 | No longer tracked |
| RLMD | June 30, 2026 | 2,947,369 | $20,513,688 | -31.4% |
| LRMR | Dec. 31, 2025 | 6,045,351 | $19,526,484 | 8.0% |
| GKOS | June 30, 2025 | 190,256 | $18,724,996 | 84.5% |
| STRO | June 30, 2026 | 715,307 | $17,818,297 | -36.3% |
| CCCC | March 31, 2025 | 4,878,000 | $17,560,800 | 150.7% |
| EYPT | June 30, 2025 | 3,181,818 | $17,245,454 | -39.6% |
| ELVN | Sept. 30, 2025 | 848,986 | $17,030,659 | 183.0% |
| CTNM | June 30, 2026 | 1,296,012 | $16,925,917 | -3.1% |
| PLRX | March 31, 2025 | 1,281,000 | $16,870,770 | -13.3% |
| TNGX | Dec. 31, 2025 | 2,000,000 | $16,800,000 | 175.6% |
| INSP | June 30, 2026 | 325,663 | $16,797,698 | 38.3% |
| PRME | Dec. 31, 2025 | 3,000,000 | $16,620,000 | -2.0% |
| CBLL | June 30, 2025 | 824,582 | $15,840,220 | 32.9% |
| NRIX | June 30, 2025 | 1,333,333 | $15,839,996 | 136.8% |
| HNGE | Sept. 30, 2025 | 300,000 | $15,525,000 | 80.6% |
| RCUS | Dec. 31, 2025 | 1,136,364 | $15,454,550 | 22.4% |
| INSM | June 30, 2025 | 200,000 | $15,258,000 | 27.6% |
| MDLN | March 31, 2026 | 335,000 | $14,070,000 | -23.7% |
| HNGE | June 30, 2026 | 364,613 | $14,059,477 | 6.8% |
| WGS | June 30, 2026 | 209,887 | $13,478,943 | 18.0% |
| ALEC | June 30, 2025 | 9,695,228 | $11,925,130 | 73.6% |
| QURE | Dec. 31, 2025 | 200,000 | $11,674,000 | 100.2% |
| SERA | June 30, 2025 | 3,032,808 | $11,160,733 | -28.2% |
| THRD | March 31, 2025 | 960,620 | $9,884,780 | No longer tracked |
| BCYC | June 30, 2025 | 1,093,477 | $9,283,620 | -41.7% |
| ELDN | Dec. 31, 2025 | 3,566,338 | $9,236,815 | 133.8% |
| CTMX | Dec. 31, 2025 | 2,661,331 | $8,489,646 | -17.8% |
| ARVN | March 31, 2025 | 421,348 | $8,077,241 | 34.9% |
| IMTX | June 30, 2025 | 1,750,000 | $7,892,500 | 63.2% |
| SRZN | Dec. 31, 2025 | 602,626 | $7,764,836 | 5.6% |
| DRUG | June 30, 2025 | 206,427 | $7,445,822 | 215.8% |
| OMDA | Sept. 30, 2025 | 400,000 | $7,320,000 | 11.3% |
| BBNX | Sept. 30, 2025 | 500,000 | $7,280,000 | 1.1% |
| ACRS | June 30, 2025 | 4,666,667 | $7,140,001 | 350.7% |
| XNCR | June 30, 2025 | 575,000 | $6,118,000 | 240.8% |
| ENTA | March 31, 2025 | 1,038,000 | $5,968,500 | 144.4% |
| HUMA | June 30, 2025 | 3,312,356 | $5,647,567 | -66.8% |
| TXG | Sept. 30, 2025 | 475,343 | $5,504,472 | 433.4% |
| MPLT | June 30, 2026 | 248,294 | $5,047,817 | -66.8% |
| EVH | Dec. 31, 2025 | 579,052 | $4,898,780 | 14.4% |
| GKOS | Dec. 31, 2025 | 54,180 | $4,418,379 | 68.7% |
| MBX | Sept. 30, 2025 | 377,841 | $4,311,166 | 281.0% |
| ZURA | June 30, 2025 | 3,217,503 | $4,150,579 | 444.8% |
| BIOA | June 30, 2025 | 1,052,494 | $3,957,377 | 150.8% |
| BOLD | June 30, 2025 | 2,180,631 | $3,292,753 | 186.1% |
| TARA | Sept. 30, 2025 | 1,039,295 | $3,149,064 | -10.1% |
| EXAS | Dec. 31, 2025 | 54,939 | $3,005,713 | No longer tracked |
| STRO | June 30, 2025 | 4,434,637 | $2,885,175 | 2878.9% |
| IFRX | Dec. 31, 2025 | 1,973,233 | $2,644,132 | 109.9% |
| PGNY | March 31, 2026 | 96,628 | $2,481,407 | 56.0% |
| QGENXXXX | March 31, 2026 | 43,976 | $2,081,683 | No longer tracked |
| ACHC | Sept. 30, 2025 | 89,262 | $2,025,355 | 11.9% |
| KIDS | March 31, 2026 | 109,959 | $1,952,872 | 65.3% |
| HCAT | March 31, 2026 | 793,749 | $1,897,060 | 33.9% |
| LXEO | June 30, 2025 | 546,554 | $1,896,542 | 29.6% |
| ALLK | March 31, 2025 | 1,129,931 | $1,367,217 | No longer tracked |
| RGLS | March 31, 2025 | 336,843 | $532,212 | No longer tracked |
| SCLXXXXX | June 30, 2025 | 1,036,218 | $257,500 | No longer tracked |